From: Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children
PATIENT | CHOLESTEROL | HDL-cho | LDL-cho | TG | GLUCOSE | INSULIN | C-PEPTIDE |
---|---|---|---|---|---|---|---|
(mg/dl) | (mg/dl) | (mg/dl) | (mg/dl) | (mg/dl) | (IU/ml) | (ng/ml) | |
Values 0–12 m | 0–12 m | 0–12 m | 0–12 m | 0–12 m | 0–12 m | 0–12 m | |
1 | 250–182 | 40–47 | 179–127 | 155–36 | 99–97 | 8,9–8,4 | 1,1–1,6 |
2 | 192–200 | NA – 65 | NA – 126 | 70–41 | 91–84 | 4,8–5,2 | 0,8–1,93 |
3 | 338–245 | 63–69 | 112–160 | 112–59 | 86–94 | 4,6-NA | 0,74-NA |
4 | 325–290 | 56–61 | 250–193 | 92–177 | 85–86 | 9,6–8,9 | 1,8-NA |
5 | 188–152 | 32–48 | 133–93 | 116–92 | 88–88 | 9,8–19,4 | 0,5–0,4 |
6 | 120–101 | 37–35 | 71–60 | 60–29 | 75–78 | 10–12,3 | 2,2–1,3 |
7 | 195–220 | 45–52 | 126–150 | 118–86 | 81–85 | 10–6,9 | 1,1–1,4 |
median at baseline | 195(120,338) | 45(32,63) | 129(71,250) | 74(60,92) | 86(75,99) | 9,6(4,6–10) | 1,3(0,5–2,5) |
median at 12 m | 200(101,290) | 52(35,69) | 127(60,193) | 74(29,177) | 87(78,97) | 8,6(5,2–19,9) | 1,4(0,4–1,93 |
P | 0,09 | 0,04 | 0,34 | 0,17 | 0,4 | 0,9 | 0,9 |